Literature DB >> 29325172

PRES: Review of Histological Features.

Nicholas Willard1, Justin M Honce2, B K Kleinschmidt-DeMasters1,3.   

Abstract

Posterior reversible encephalopathy syndrome was described in 1996 as a clinical-neuroimaging entity characterized by parieto-occipital watershed-region edema without overt infarction. It has been linked to hypertension, eclampsia, immunosuppressive therapies, infections, and autoimmune disorders. The condition usually has an acute onset, presents with seizures, and ameliorates within days. There have been few neuropathological studies, but in some cases, tissue damage may be more permanent.
© 2017 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Autoimmune; Cyclosporin; Encephalopathy; Immunosuppression; Leukoencephalopathy; Parieto-occipital; Renal failure

Mesh:

Year:  2018        PMID: 29325172     DOI: 10.1093/jnen/nlx112

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  4 in total

1.  Blood-Brain Barrier Disruption as a Potential Target for Therapy in Posterior Reversible Encephalopathy Syndrome: Evidence From Multimodal MRI in Rats.

Authors:  Quanlai Wang; Bin Huang; Guiquan Shen; Yu Zeng; Zheng Chen; Chunqiang Lu; Alexander Lerner; Bo Gao
Journal:  Front Neurol       Date:  2019-11-26       Impact factor: 4.003

2.  Circulating microRNAs May Serve as Biomarkers for Hypertensive Emergency End-Organ Injuries and Address Underlying Pathways in an Animal Model.

Authors:  Knut Asbjørn Rise Langlo; Gustavo Jose Justo Silva; Tina Syvertsen Overrein; Volker Adams; Ulrik Wisløff; Håvard Dalen; Natale Rolim; Stein Ivar Hallan
Journal:  Front Cardiovasc Med       Date:  2021-02-12

3.  Delayed Presentation of Posterior Reversible Encephalopathy Syndrome in the Setting of Serotonin-Norepinephrine Reuptake Inhibitors.

Authors:  Abhishek S Bhutada; Thomas V Kodankandath
Journal:  Cureus       Date:  2022-02-21

4.  Posterior Reversible Encephalopathy Syndrome Associated with Tacrolimus in Cardiac Transplantation.

Authors:  Julián Alejandro Rivillas; Stephania Galindo-Coral; Francisco Arias-Mora; Juan David Lopez-Ponce de Leon; Noel Alberto Florez-Alarcón; Pastor Olaya-Rojas; Juan Esteban Gomez-Mesa
Journal:  Case Rep Cardiol       Date:  2021-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.